| Mia Nepomuceno-perez, MD | |
|
11370 Anderson St, Ste 2960, Loma Linda, CA 92354-3450 | |
| (909) 558-6422 | |
| Not Available |
| Full Name | Mia Nepomuceno-perez |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 32 Years |
| Location | 11370 Anderson St, Loma Linda, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073533519 | NPI | - | NPPES |
| 00A655930 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZC0500X | Pathology - Cytopathology | A65593 (California) | Secondary |
| 207ZP0101X | Pathology - Anatomic Pathology | A65593 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Loma Linda University Medical Center | Loma linda, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Faculty Physicians And Surgeons Of Llusm | 1153227814 | 1053 |
| Loma Linda University Pathology Medical Group, Inc | 1355234972 | 16 |
News Archive
Walter and Eliza Hall Institute scientists have identified a key step in the biological process of programmed cell death, also called apoptosis.
A shocking new study led by Harvard T.H. Chan School of Public Health reveals that by 2030, just a decade away, almost half of all Americans will be suffering from obesity – making this the biggest epidemic ever in history. And that's not all – half of these obese individuals will be severely obese, or, to put it in simple terms, they will be over their expected weight by more than 100 pounds.
Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine's efficacy in treating asthma patients and is not currently approved for this indication.
As cannabis laws become liberalised in many countries, experts writing in The Lancet Psychiatry argue that there is an urgent need to explore how cannabis use can be made safer.
Some time mid last year six breast cancer patients sued reputed Myriad Genetics, a company that holds patent of two vital genes BRCA1 and BRCA2 that play a role in increasing the risk of breast and ovarian cancers. The fees that the company charges for these genetic tests is a whopping $3,000 which these women claim they cannot afford and the most important of all these women cannot get a second opinion regarding the tests since no one else does them.
› Verified 7 days ago
| Entity Name | Faculty Physicians And Surgeons Of Llusm |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205009917 PECOS PAC ID: 1153227814 Enrollment ID: O20031211000981 |
News Archive
Walter and Eliza Hall Institute scientists have identified a key step in the biological process of programmed cell death, also called apoptosis.
A shocking new study led by Harvard T.H. Chan School of Public Health reveals that by 2030, just a decade away, almost half of all Americans will be suffering from obesity – making this the biggest epidemic ever in history. And that's not all – half of these obese individuals will be severely obese, or, to put it in simple terms, they will be over their expected weight by more than 100 pounds.
Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine's efficacy in treating asthma patients and is not currently approved for this indication.
As cannabis laws become liberalised in many countries, experts writing in The Lancet Psychiatry argue that there is an urgent need to explore how cannabis use can be made safer.
Some time mid last year six breast cancer patients sued reputed Myriad Genetics, a company that holds patent of two vital genes BRCA1 and BRCA2 that play a role in increasing the risk of breast and ovarian cancers. The fees that the company charges for these genetic tests is a whopping $3,000 which these women claim they cannot afford and the most important of all these women cannot get a second opinion regarding the tests since no one else does them.
› Verified 7 days ago
| Entity Name | Loma Linda University Pathology Medical Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457398505 PECOS PAC ID: 1355234972 Enrollment ID: O20040301000597 |
News Archive
Walter and Eliza Hall Institute scientists have identified a key step in the biological process of programmed cell death, also called apoptosis.
A shocking new study led by Harvard T.H. Chan School of Public Health reveals that by 2030, just a decade away, almost half of all Americans will be suffering from obesity – making this the biggest epidemic ever in history. And that's not all – half of these obese individuals will be severely obese, or, to put it in simple terms, they will be over their expected weight by more than 100 pounds.
Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine's efficacy in treating asthma patients and is not currently approved for this indication.
As cannabis laws become liberalised in many countries, experts writing in The Lancet Psychiatry argue that there is an urgent need to explore how cannabis use can be made safer.
Some time mid last year six breast cancer patients sued reputed Myriad Genetics, a company that holds patent of two vital genes BRCA1 and BRCA2 that play a role in increasing the risk of breast and ovarian cancers. The fees that the company charges for these genetic tests is a whopping $3,000 which these women claim they cannot afford and the most important of all these women cannot get a second opinion regarding the tests since no one else does them.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mia Nepomuceno-perez, MD Po Box 1740, Loma Linda, CA 92354-0240 Ph: (909) 558-6422 | Mia Nepomuceno-perez, MD 11370 Anderson St, Ste 2960, Loma Linda, CA 92354-3450 Ph: (909) 558-6422 |
News Archive
Walter and Eliza Hall Institute scientists have identified a key step in the biological process of programmed cell death, also called apoptosis.
A shocking new study led by Harvard T.H. Chan School of Public Health reveals that by 2030, just a decade away, almost half of all Americans will be suffering from obesity – making this the biggest epidemic ever in history. And that's not all – half of these obese individuals will be severely obese, or, to put it in simple terms, they will be over their expected weight by more than 100 pounds.
Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine's efficacy in treating asthma patients and is not currently approved for this indication.
As cannabis laws become liberalised in many countries, experts writing in The Lancet Psychiatry argue that there is an urgent need to explore how cannabis use can be made safer.
Some time mid last year six breast cancer patients sued reputed Myriad Genetics, a company that holds patent of two vital genes BRCA1 and BRCA2 that play a role in increasing the risk of breast and ovarian cancers. The fees that the company charges for these genetic tests is a whopping $3,000 which these women claim they cannot afford and the most important of all these women cannot get a second opinion regarding the tests since no one else does them.
› Verified 7 days ago
James M Pappas, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 11370 Anderson St Ste 2890, Loma Linda, CA 92354 Phone: 909-558-2304 | |
Yan Chen Wongworawat, MD, PHD Pathology Medicare: Medicare Enrolled Practice Location: 11234 Anderson St, Loma Linda University Health-pathology, Loma Linda, CA 92354 Phone: 909-558-4094 | |
Wilson Chick, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 11370 Anderson St, Ste 2960, Loma Linda, CA 92354 Phone: 909-558-6422 | |
Mrs. Laura Jean Denham, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 11234 Anderson St Ste 2516, Loma Linda, CA 92354 Phone: 909-558-4094 Fax: 909-793-2931 | |
Ravi K Raghavan, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 11370 Anderson St, Ste 2960, Loma Linda, CA 92354 Phone: 909-558-6422 | |
Pamela J Wat, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 11370 Anderson St, Ste 2960, Loma Linda, CA 92354 Phone: 909-558-6422 |